Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) Stock: Insider Dagi Shahar Ben-Noon Acquires 14,093 Shares

Inspira Technologies OXY B.H.N. Ltd (NASDAQ:QTEX) CEO Dagi Ben-Noon bought 14,093 shares of the firm’s stock in a transaction that occurred on Tuesday, October 13th. The shares were acquired at an average price of $1.49 per share, with a total value of $20,998.57. Following the purchase, the chief executive officer owned 14,093 shares in the company, valued at $20,998.57. This trade represents a ? increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Dagi Shahar Ben-Noon also recently made the following trade(s):

• On Friday, October 9th, Dagi Ben-Noon bought 18,181 shares of Inspira Technologies OXY B.H.N. stock. The stock was acquired at an average cost of $1.67 per share, for a total transaction of $30,362.27.
• On Monday, September 28th, Dagi Ben-Noon bought 168,894 shares of Inspira Technologies OXY B.H.N. stock. The stock was acquired at an average cost of $0.71 per share, for a total transaction of $119,914.74.

Inspira Technologies OXY B.H.N. Stock Down 7.6%

Shares of NASDAQ QTEX opened at $1.46 on Thursday. The company has a current ratio of 2.00, a quick ratio of 1.62 and a debt-to-equity ratio of 0.12. The stock has a 50 day simple moving average of $0.99. Inspira Technologies OXY B.H.N. Ltd has a 12 month low of $0.28 and a 12 month high of $3.85.

Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) last issued its quarterly earnings results on Thursday, September 24th. The company reported ($0.07) EPS for the quarter. The firm had revenue of $0.78 million during the quarter.

Inspira Technologies OXY B.H.N. announced that its Board of Directors has initiated a stock repurchase program on Monday, June 22nd that authorizes the company to buy back 2,000,000,000,000 outstanding shares. This repurchase authorization authorizes the company to reacquire up to 5.6% of its shares through open market purchases. Stock repurchase programs are often an indication that the company’s board of directors believes its stock is undervalued.

Wall Street Analyst Weigh In

QTEX has been the subject of several research analyst reports. Weiss Ratings cut shares of Inspira Technologies OXY B.H.N. from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Friday, October 9th. Wall Street Zen downgraded shares of Inspira Technologies OXY B.H.N. from a “hold” rating to a “sell” rating in a report on Saturday, August 8th. One analyst has rated the stock with a Sell rating. According to data from MarketBeat, Inspira Technologies OXY B.H.N. has a consensus rating of “Sell”.

Inspira Technologies OXY B.H.N. Company Profile

Inspira Technologies OXY B.H.N. Ltd. is a medical technology company focused on developing advanced respiratory-support and blood-monitoring solutions for critical-care settings. The company’s technologies are intended to help address complications associated with respiratory failure and improve the management of patients requiring oxygenation support.

Its product portfolio includes the INSPIRA ART system, an extracorporeal respiratory-support platform designed to provide oxygenation while potentially reducing the need for conventional mechanical ventilation or more complex extracorporeal membrane oxygenation procedures.